Europe - OSL:LIFE - NO0013355859 - Common Stock
The current stock price of LIFE.OL is 5.34 NOK. In the past month the price decreased by -41.58%. In the past year, price decreased by -70.33%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 25.46 | 190.51B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 63.86 | 169.63B | ||
| 1ISRG.MI | INTUITIVE SURGICAL INC | 54.06 | 143.61B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 34.57 | 130.10B | ||
| 1BSX.MI | BOSTON SCIENTIFIC CORP | 35.45 | 127.13B | ||
| 2M6.DE | MEDTRONIC PLC | 16.88 | 103.08B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 20.81 | 55.87B | ||
| BOX.DE | BECTON DICKINSON AND CO | 13.03 | 45.89B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 29.82 | 38.70B | ||
| DC4.DE | DEXCOM INC | 42.04 | 24.07B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 17.3 | 23.99B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 17.22 | 23.88B |
Lifecare ASA engages in the research, testing, and development of medical sensors for health monitoring. The company is headquartered in Bergen, Hordaland and currently employs 30 full-time employees. The company went IPO on 2018-07-10. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
LIFECARE ASA
Ytrebygdsvegen 215
Bergen HORDALAND NO
Employees: 32
Phone: 4740059040
Lifecare ASA engages in the research, testing, and development of medical sensors for health monitoring. The company is headquartered in Bergen, Hordaland and currently employs 30 full-time employees. The company went IPO on 2018-07-10. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
The current stock price of LIFE.OL is 5.34 NOK. The price decreased by -4.64% in the last trading session.
LIFE.OL does not pay a dividend.
LIFE.OL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
LIFE.OL stock is listed on the Euronext Oslo exchange.
null analysts have analysed LIFE.OL and the average price target is 36.72 NOK. This implies a price increase of 587.64% is expected in the next year compared to the current price of 5.34.
LIFECARE ASA (LIFE.OL) has a market capitalization of 101.78M NOK. This makes LIFE.OL a Micro Cap stock.
ChartMill assigns a fundamental rating of 3 / 10 to LIFE.OL. LIFE.OL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months LIFE.OL reported a non-GAAP Earnings per Share(EPS) of -16.5. The EPS decreased by -41.51% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -92.41% | ||
| ROE | -123.73% | ||
| Debt/Equity | 0.12 |
null analysts have analysed LIFE.OL and the average price target is 36.72 NOK. This implies a price increase of 587.64% is expected in the next year compared to the current price of 5.34.
For the next year, analysts expect an EPS growth of 4.06% and a revenue growth -50% for LIFE.OL